Drug intelligence / Profile preview

lipoic acid trisulfide

Development stage
Preclinical
Lead developer
Kyowa Kirin
Modality
Small Molecules
Administration
Oral
01

Overview

Lipoic acid trisulfide (LATS) is a small molecule derivative of lipoic acid containing a trisulfide bridge, designed to function as a hydrogen sulfide (H2S) donor. It serves as the monomeric precursor for the polymeric nanomedicine poly(lipoic acid trisulfide) (pLATS). LATS undergoes thiol-triggered intracellular exchange and depolymerization to release H2S and lipoic acid (LA), which together provide synergistic antihypertensive and renoprotective effects. The molecule modulates the renin-angiotensin system and improves endothelial function, while also upregulating endogenous H2S-producing enzymes to promote sustained H2S biogenesis. It is primarily investigated for the treatment of hypertensive chronic kidney disease (CKD), where it has demonstrated the ability to lower blood pressure and improve renal biomarkers such as the urine albumin-to-creatinine ratio.

Other names
LATS
02

Targets

H2S (Hydrogen sulfide)CTH (Cystathionine gamma-lyase)

Beyond the preview

Go deeper on lipoic acid trisulfide.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on lipoic acid trisulfide.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call